Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome
Completed · Phase 3 · NCT06173531
Conditions: Hyperphagia in Prader-Willi Syndrome
At a glance
- Research payments reported, 2025
- $1.7M
- U.S. investigators named
- 23
- Sites paid
- 26
- Planned or actual enrollment
- 175
About the trial
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Tested
- Carbetocin (drug), Placebo (drug)
- Dates
- Started 2023-11-27; completion 2025-08-19
- Results posted
- Yes
12-week, randomized, double-blind, placebo-controlled, parallel-group study of carbetocin nasal spray for the treatment of hyperphagia in Prader-Willi syndrome (PWS)
From ClinicalTrials.gov, last updated 2026-10-15. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Acadia Pharmaceuticals Inc reported $1.7M in research payments for this study in 2025 (130 payments).
Products named: Acp-101
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Parisa Salehi, M.D. Pediatric Endocrinology · Fairbanks, AK
- Hussein D. Abdul-latif, M.D. Pediatric Endocrinology · Birmingham, AL
- Oliver J. Oatman, DO Pediatric Endocrinology · Phoenix, AZ
- Lynne M. Bird, M.D. Medical Genetics · San Diego, CA
- Virginia E. Kimonis, MD Medical Genetics · Orange, CA
- Diane E. Stafford, M.D. Pediatric Endocrinology · Palo Alto, CA
- Shawn E. Mccandless, MD Medical Genetics · Aurora, CO
- Han C. Phan, MD Child Neurology · Atlanta, GA
- Michael J. Tansey, MD Pediatric Endocrinology · Iowa City, IA
- Peter T. Heydemann, M.D. Child Neurology · Chicago, IL
- Jill Samis, MD Pediatric Endocrinology · Chicago, IL
- Charumathi Baskaran, MD Pediatric Endocrinology · Boston, MA
- Constance Smith-hicks, M.D. Child Neurology · Baltimore, MD
- Jennifer L. Heithaus, MD Developmental-Behavioral Pediatrics · Saint Louis, MO
- Emily Paprocki, D.O. Pediatric Endocrinology · Kansas City, MO
- Deepan Singh, M.D. Psychiatry · Glen Oaks, NY
- Kathryn S. Obrynba, M.D. Pediatric Endocrinology · Columbus, OH
- Gerard Vockley, MD, PHD Specialist · Pittsburgh, PA
- Italo Biaggioni, MD Clinical Pharmacology · Nashville, TN
- Kathy Hwu, MD Pediatric Endocrinology · Houston, TX
- Sani A. Roy, M.D. Pediatric Endocrinology · Fort Worth, TX
- Ann Scheimann, M.D. Pediatric Gastroenterology · Houston, TX
- David H. Viskochil, MD Medical Genetics · Salt Lake City, UT
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Children's Hospital Colorado, CO $184,702
- Ann & Robert H Lurie Childrens Hospital of Chicago, IL $177,368
- Boston Children's Hospital, MA $159,450
- Phoenix Children's Hospital, AZ $143,314
- The Regents of the University of California $108,073
- Baylor College of Medicine $93,801
- Board of Trustees of the Leland Stanford Junior University $90,575
- Seattle Children's Hospital, WA $84,438
- Rare Disease Research LLC $64,500
- Maimonides Medical Center, NY $60,340
- St Louis University $59,199
- Uci Health-Orange, CA $55,211
- University of Alabama Hospital, AL $51,561
- University of Utah Hospital and Clinics, UT $49,989
- Cook Children S Health Care System $46,267
- University of Iowa Hospital & Clinics, IA $43,783
- The Children's Mercy Hospital, MO $42,955
- UPMC Children's Hospital of Pittsburgh, PA $39,718
- Johns Hopkins University $29,785
- University of Pittsburgh Physicians $28,218
- Cook Childrens Health Care System $26,277
- Hugo W Moser Research Institute at Kennedy Krieger Inc $23,100
- The Research Institute at Nationwide Children's Hosp $20,544
- Vanderbilt University Medical Center, TN $11,563
- Regents of the University of California at Irvine $4,282
- Rush University Medical Center, IL $3,900
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.